Bogdan Petrunov

"I do not believe that Omicron will end the pandemic. New variants of the virus are constantly appearing. The mutation of the virus is a normal biological process. For every virus - not just this one. There will be many other mutations. The question is not whether the pandemic with Omicron will disappear, but what measures will be taken.

"Like the flu, immunizations will be made every year, based on circulating variants, which is the only salvation. The annual vaccine is the solution. The three elements - vaccines, drugs and compliance with anti-epidemic measures, which we forget, are the only salvation until the virus is turned into a common infectious respiratory seasonal disease.

"Issuing Bulgarian green certificates for antibodies is a mistake. They are not allowed and are not given anywhere in the world. There are many reasons for this." this was stated by Academician Bogdan Petrunov in the studio of "Awake".

"It became clear to everyone that the reason for the large number of people infected with COVID-19 in our country is the non-compliance with the measures. If they are introduced more strictly, people will be disciplined." This was stated in tv interview by academician Bogdan Petrunov.

There is no doubt that the third dose of vaccine will be needed, but without haste. 8-10 months after illness or vaccination, a booster dose can be given. This was commented in "The day begins" on BNT by Acad. Bogdan Petrunov, immunologist and allergist.

The new strain of COVID-19 has largely blocked Britain and Europe in terms of transport.

Immunologist Acad. Bogdan Petrunov explained that the appearance of this strain should not surprise us and there is no reason to panic.

"This is a completely natural evolutionary path for the development of viruses that mutate constantly," he said.

In the worldwide battle against COVID-19, scientists are investigating whether a century-old tuberculosis vaccine might offer some additional protection against the novel coronavirus.

And Bulgaria -- one of the world's leading manufacturers of the vaccine -- is holding out hope of new markets for the many millions of doses it produces each year.